FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2942594179> ?p ?o ?g. }

• W2942594179 abstract "Neuromyelitis optica (NMO) is a severe inflammatory autoimmune disorder of the central nervous system and often results in paralysis or blindness. Rituximab (RTX) is a mouse–human chimeric monoclonal antibody specific for the CD20 antigen on B lymphocytes and used to treat many autoimmune diseases. Disability and relapses were measured using the Expanded Disability Status Scale (EDSS) and annualized relapse rate (ARR) ratio to evaluate the effectiveness of RTX. This review performed a meta-analysis of the efficacy of RTX in NMO. We searched through the databases of PubMed, Embase, and Cochrane Library. We compiled 26 studies, in which 18 used ARR ratio, 22 used EDSS score, and 14 used both variables. Differences in the ARR ratio and EDSS score before and after RTX therapy were used as the main efficacy measures. Publication bias was evaluated after the consistency test, and a sensitivity analysis was performed with mean difference (MD) of the efficacy of RTX. A meta-analysis of 26 studies with 577 participants was conducted. Antibodies against aquaporin-4 autoantibody were recorded in 435 of 577 (75.39%) patients with NMO. RTX therapy resulted in a mean (WMD) − 1.56 (95% CI, − 1.82 to − 1.29) reduction in the mean ARR ratio and a mean (WMD) − 1.16 (95% CI, − 1.36 to − 0.96) reduction in the mean EDSS score. A total of 330 of 528 patients (62.9%) reached the relapse-free state. A total of 95 of 577 (16.46%) patients had adverse reactions. RTX has acceptable tolerance, reduces the relapse frequency, and improves disability in most patients with NMO. Future studies should focus on reducing the health-care costs, improving the functional outcomes, and reducing the adverse effects associated with RTX treatment." @default.
• W2942594179 created "2019-05-09" @default.
• W2942594179 creator A5001012522 @default.
• W2942594179 creator A5002745232 @default.
• W2942594179 creator A5017519380 @default.
• W2942594179 creator A5044544424 @default.
• W2942594179 creator A5052589632 @default.
• W2942594179 creator A5054783277 @default.
• W2942594179 creator A5055919704 @default.
• W2942594179 date "2019-03-06" @default.
• W2942594179 modified "2023-10-06" @default.
• W2942594179 title "Effectiveness of rituximab in neuromyelitis optica: a meta-analysis" @default.
• W2942594179 cites W1169148024 @default.
• W2942594179 cites W1522374426 @default.
• W2942594179 cites W1823172479 @default.
• W2942594179 cites W1968379389 @default.
• W2942594179 cites W1968634262 @default.
• W2942594179 cites W1972241906 @default.
• W2942594179 cites W2005486905 @default.
• W2942594179 cites W2021279859 @default.
• W2942594179 cites W2023686387 @default.
• W2942594179 cites W2027269546 @default.
• W2942594179 cites W2029600633 @default.
• W2942594179 cites W2082237468 @default.
• W2942594179 cites W2087529564 @default.
• W2942594179 cites W2089363506 @default.
• W2942594179 cites W2100093402 @default.
• W2942594179 cites W2106308432 @default.
• W2942594179 cites W2109266689 @default.
• W2942594179 cites W2128597204 @default.
• W2942594179 cites W2129229339 @default.
• W2942594179 cites W2130342500 @default.
• W2942594179 cites W2142340239 @default.
• W2942594179 cites W2185400242 @default.
• W2942594179 cites W2296419904 @default.
• W2942594179 cites W2330155556 @default.
• W2942594179 cites W2418688327 @default.
• W2942594179 cites W2525224202 @default.
• W2942594179 cites W2539211723 @default.
• W2942594179 cites W2551229111 @default.
• W2942594179 cites W2561708624 @default.
• W2942594179 cites W2570909152 @default.
• W2942594179 cites W2625404774 @default.
• W2942594179 cites W2747029006 @default.
• W2942594179 cites W2778216211 @default.
• W2942594179 cites W2781286807 @default.
• W2942594179 cites W2790223348 @default.
• W2942594179 cites W2791305328 @default.
• W2942594179 doi "https://doi.org/10.1186/s12883-019-1261-2" @default.
• W2942594179 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6402122" @default.
• W2942594179 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30841862" @default.
• W2942594179 hasPublicationYear "2019" @default.
• W2942594179 type Work @default.
• W2942594179 sameAs 2942594179 @default.
• W2942594179 citedByCount "76" @default.
• W2942594179 countsByYear W29425941792019 @default.
• W2942594179 countsByYear W29425941792020 @default.
• W2942594179 countsByYear W29425941792021 @default.
• W2942594179 countsByYear W29425941792022 @default.
• W2942594179 countsByYear W29425941792023 @default.
• W2942594179 crossrefType "journal-article" @default.
• W2942594179 hasAuthorship W2942594179A5001012522 @default.
• W2942594179 hasAuthorship W2942594179A5002745232 @default.
• W2942594179 hasAuthorship W2942594179A5017519380 @default.
• W2942594179 hasAuthorship W2942594179A5044544424 @default.
• W2942594179 hasAuthorship W2942594179A5052589632 @default.
• W2942594179 hasAuthorship W2942594179A5054783277 @default.
• W2942594179 hasAuthorship W2942594179A5055919704 @default.
• W2942594179 hasBestOaLocation W29425941791 @default.
• W2942594179 hasConcept C118552586 @default.
• W2942594179 hasConcept C126322002 @default.
• W2942594179 hasConcept C159654299 @default.
• W2942594179 hasConcept C16568411 @default.
• W2942594179 hasConcept C197934379 @default.
• W2942594179 hasConcept C203014093 @default.
• W2942594179 hasConcept C2776478404 @default.
• W2942594179 hasConcept C2780640218 @default.
• W2942594179 hasConcept C2780653079 @default.
• W2942594179 hasConcept C2780892749 @default.
• W2942594179 hasConcept C2781137167 @default.
• W2942594179 hasConcept C44249647 @default.
• W2942594179 hasConcept C71924100 @default.
• W2942594179 hasConcept C82789193 @default.
• W2942594179 hasConcept C95190672 @default.
• W2942594179 hasConceptScore W2942594179C118552586 @default.
• W2942594179 hasConceptScore W2942594179C126322002 @default.
• W2942594179 hasConceptScore W2942594179C159654299 @default.
• W2942594179 hasConceptScore W2942594179C16568411 @default.
• W2942594179 hasConceptScore W2942594179C197934379 @default.
• W2942594179 hasConceptScore W2942594179C203014093 @default.
• W2942594179 hasConceptScore W2942594179C2776478404 @default.
• W2942594179 hasConceptScore W2942594179C2780640218 @default.
• W2942594179 hasConceptScore W2942594179C2780653079 @default.
• W2942594179 hasConceptScore W2942594179C2780892749 @default.
• W2942594179 hasConceptScore W2942594179C2781137167 @default.
• W2942594179 hasConceptScore W2942594179C44249647 @default.
• W2942594179 hasConceptScore W2942594179C71924100 @default.
• W2942594179 hasConceptScore W2942594179C82789193 @default.
• W2942594179 hasConceptScore W2942594179C95190672 @default.
• W2942594179 hasIssue "1" @default.

• next